Sun Pharma shares rose to a new 52-week high on Tuesday after its subsidiary Taro Pharmaceutical Industries posted strong results on Monday.
Sun Pharma shares however ended flat on Tuesday at 669.15 on profit-taking. During Tuesday's session, Sun Pharma shares hit a new 52-week high of 684 on BSE.
Sun Pharma will announce its
first quarter results on August 10, 2012.
On Monday, Sun Pharma's subsidiary Taro Pharma said its net sales rose 42 per cent to $159.2 million, for the three month period ending June 30, 2012.
Net income attributable to Taro during the quarter was $62.9 million.
Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Special 
